ClinicalTrials.gg
Drug

Carbetocin clinical trials

Also written Duratocin, Pabal and ACP-101.

studies test it
73
open now
7
in phase 3
12
first study started
2009

How each study uses carbetocin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the carbetocin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Carbetocin
67
Active Comparator
3
Lonactene
2

Brand

Duratocin
15
Pabal
14

Development codes

ACP-101
2
FE 992097
1
LV-101
1

Studies by the year they started

73 studies that test it; most in 2018 (10)

Studies that test carbetocin, by start year
YearStudies
20091
20102
20111
20129
20133
20148
20156
20162
20171
201810
20197
20204
20214
20223
20235
20242
20252
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
2
Phase 2
3
Phase 3
12
Phase 4
28
No phase
26

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 67

Cairo University (12) · Samuel Lunenfeld Research Institute, Mount Sinai Hospital (11) · Aswan University Hospital (4) · Oslo University Hospital (3) · Beni-Suef University (3) · ACADIA Pharmaceuticals Inc. (2) · Ferring Pharmaceuticals (2) · University of British Columbia (2)

Often tested with

Tested in the same studies.

Oxytocin (21) · Misoprostol (10) · Ergonovine (2) · Syntometrine (1) · Whole blood (1) · Methylergonovine (1) · Terlipressin (1) · Arginine Vasopressin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test carbetocin.

Studies

Open first, then newest update. How each study uses carbetocin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 73

See all 73 studies that test carbetocin →

Given beside what is tested · 5 — carbetocin is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with carbetocin

Codes

What other systems call carbetocin · ClinicalTrials.gg INT002728

  • MeSH (NLM) C020731carbetocinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 88TWF8015YCARBETOCINConfirmed FDA, NLM, Wikidata
  • Wikidata Q5037853carbetocinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C96858CarbetocinOne source FDA
  • DrugBank DB01282One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.